These findings together with the above results suggested that BiVax/IL2Cx generates CD8 T cell responses that have the capacity to recognize self-antigen in the pancreas of RIP-gp mice and resist PD-1 inhibition signals leading to the onset of diabetes. This evidence concerns the gene CD8A and diabetes mellitus.